Latest news with #SNY
USA Today
2 hours ago
- Sport
- USA Today
Mets vs. Braves Tickets, First Pitch Time for Wednesday, June 25
Mets vs. Braves Tickets, First Pitch Time for Wednesday, June 25 The New York Mets and Francisco Lindor will hit the field against the Atlanta Braves and Matt Olson on Wednesday, June 25 at 7:10 p.m. ET (on SNY and FDSSO). Buy Mets Tickets on SeatGeek Buy Mets Tickets on StubHub Mets vs. Braves Game Info Game day: Wednesday, June 25, 2025 Wednesday, June 25, 2025 Game time: 7:10 p.m. ET 7:10 p.m. ET TV channel: SNY and FDSSO SNY and FDSSO Live Stream: Watch LIVE with Fubo! (Regional restrictions may apply) Watch LIVE with Fubo! Location: Queens, New York Queens, New York Stadium: Citi Field Citi Field Mets Starter: TBA TBA Braves Starter: TBA Mets vs. Braves Tickets For Sale Mets vs. Braves offensive insights The Mets have hit 67 homers this season, which ranks 10th in the league. Hitters for New York rank sixth in the majors with a combined .414 team slugging percentage. The Mets have a team batting average of .246 this season, which ranks 15th among MLB teams. The Braves are 12th in baseball with 62 home runs. They average 1.1 per game. So far this year, Atlanta is 17th in baseball, slugging .389. The Braves have the 15th-ranked batting average in the league (.246). Watch MLB on Fubo Mets' top hitters Lindor is batting .282 this season, with a .846 OPS (.354 on-base, .491 slugging). He has 13 home runs and 34 RBI, plus 38 runs scored and 10 steals on 12 attempts. His strikeout rate is 17.5%, and his walk rate is 8.2%. So far this season, Pete Alonso is hitting .288, with a .927 OPS (.384 on-base, .543 slugging). His strikeout rate is 21.3%, and his walk rate is 11.6%. He has 12 home runs and 46 RBI, plus 32 runs scored. Juan Soto's current batting average is .233, and he has 10 home runs and 28 RBI, plus 38 runs scored and seven steals on seven attempts. His strikeout rate is 16.2%, and his walk rate is 17%. He has a .363 on-base percentage, and a .429 slugging percentage. Also for the Mets, Brandon Nimmo's batting average is .231, with a .292 on-base percentage and a .417 slugging percentage. His strikeout rate is 18.7%, and his walk rate is 7.8%. He has nine homers and 29 RBI, plus 24 runs scored. Braves' top hitters Marcell Ozuna, who owns a .284/.427/.474 slash line this season, has piled up 27 runs, 25 RBI, and 10 home runs in 241 PAs. His walk rate is 19.9%, and his strikeout rate is 22.4%. In 252 plate appearances this year, Olson is batting .239/.333/.459 with 12 home runs, 31 RBI and 32 runs. He's striking out at a 23.4% clip and walking 12.3% of the time. So far this season, Ozzie Albies, who has a .235/.304/.350 triple slash line, has piled up 30 runs, 22 RBI, and six dingers in 250 plate appearances. As a basestealer, he's snagged six steals on seven tries. His walk rate is 8.4%, while his strikeout rate is 15.6%. At the dish, Austin Riley, who has a .275/.335/.445 triple slash, has piled up 31 runs scored, 33 RBI, and 10 homers in 257 plate appearances. His walk rate is 7%, while his K rate is 27.6%. Mets' injuries Jose Siri: 10 Day IL (Shin), Jesse Winker: 10 Day IL (Side), Paul Blackburn: 15 Day IL (Knee), Drew Smith: 60 Day IL (Elbow), Sean Manaea: 60 Day IL (Oblique), Frankie Montás: 60 Day IL (Lat), Christian Scott: 60 Day IL (Elbow), Brooks Raley: 60 Day IL (Elbow), A.J. Minter: 60 Day IL (Lat), Danny Young: 60 Day IL (Elbow), Nick Madrigal: 60 Day IL (Shoulder) Braves' injuries Stuart Fairchild: 10 Day IL (Finger), Joe Jimenez: 60 Day IL (Knee), AJ Smith-Shawver: 60 Day IL (Calf/elbow), Ignacio Alvarez: 60 Day IL (Wrist), Reynaldo López: 60 Day IL (Shoulder) Buy Mets Tickets on SeatGeek Buy Mets Tickets on StubHub
Yahoo
2 hours ago
- Business
- Yahoo
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout
Sanofi SA (NASDAQ:SNY) on Monday agreed to acquire Blueprint Medicines Corporation (NASDAQ:BPMC). The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the U.S. and the EU, and a promising advanced and early-stage immunology pipeline. Ayvakit/Ayvakyt is the only approved medicine for advanced and indolent systemic mastocytosis (ASM & ISM), a rare immunology disease, which is characterized by the accumulation and activation of aberrant mast cells in bone marrow, skin, the gastrointestinal tract, and other organs. The acquisition will also include elenestinib, a next-generation medicine for SM, and BLU-808, a highly selective and potent oral wild-type KIT inhibitor with the potential for immunology will pay $129.00 per share in cash, representing an equity value of approximately $9.1 billion. Blueprint shareholders will also receive one contingent value right (CVR), which entitles the holder to two potential milestone payments of $2 and $4 per CVR to achieve future development and regulatory milestones for BLU-808. The total equity value of the transaction, including potential CVR payments, represents approximately $9.5 billion on a fully diluted basis. Paul Hudson, CEO of Sanofi, said, 'The proposed acquisition of Blueprint Medicines represents a strategic step forward in our rare and immunology complements recent acquisitions of early-stage medicines that remain our main field of interest. Sanofi still retains a sizeable capacity for further acquisitions.' Ayvakit achieved net revenues of $479 million in 2024 and nearly $150 million in Q1 2025, representing year-on-year growth of more than 60% over Q1 2024. Sanofi currently expects to complete the acquisition in the third quarter of 2025. The acquisition will not significantly impact Sanofi's financial guidance for 2025. It is immediately accretive to gross margin and accretive to business operating income and EPS after 2026. In another development, Sanofi exercised its option to exclusively license Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) STAT6 program on Monday, including the drug development candidate NX-3911, an oral, highly selective STAT6 degrader. STAT6 (signal transducer and activator of transcription 6) plays a central role in type 2 inflammation, which drives diseases such as atopic dermatitis and asthma. Under its 2019 collaboration agreement, Nurix will receive a $15 million license extension fee from Sanofi, bringing the total amount received under this collaboration to $127 million. Nurix is eligible for an additional $465 million in development, regulatory, and commercial milestones associated with the STAT6 program and potential future royalties and retains an option to co-develop and co-promote in the U.S. Price Action: SNY stock is trading lower by 0.73% to $49.01, BPMC stock is trading higher by 26.8% to $128.50, and NRIX stock is trading lower by 0.28% to $10.60 during the premarket session at last check Monday. Read Next:Photo by HJBC via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? SANOFI (SNY): Free Stock Analysis Report BLUEPRINT MEDICINES (BPMC): Free Stock Analysis Report This article Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
New York Post
a day ago
- Entertainment
- New York Post
Keith Hernandez had no idea how to react to ED medication ad read: ‘What did you mean by that?'
Mets announcer Gary Cohen does plenty of in-game ad reads, but this one left Keith Hernandez beyond confused. Ahead of the top of the eighth inning in Saturday's Mets win over the Rockies that aired on WPIX, Cohen did an ad read for BlueChew, a medication for erectile dysfunction, in which he told viewers to 'chew it and do it.' Hernandez was left perplexed by Cohen's statement, asking him the meaning behind it after a brief pause. Advertisement Gary Cohen: "By BlueChew. Chew it and do it." Keith Hernandez: "What did you mean by that?" Gary Cohen: "I just read the copy here. I try to give it a good read. Try and give the advertiser everything that they paid for, Keith. And then it's somebody else's problem." #MLB — Awful Announcing (@awfulannouncing) May 31, 2025 'What did you mean by that?' Hernandez said. Cohen responded by saying he was simply reading what was given to him. Advertisement 'I just read the copy here,' Cohen replied once the eighth inning began. 'I try to give it a good read. Try and give the advertiser everything that they paid for, Keith. And then it's somebody else's problem.' Gary Cohen, Ron Darling and Keith Hernandez celebrate 20 years on SNY. SNY The Mets' broadcast crew, which consists of Cohen, Hernandez and Ron Darling and mostly calls games on SNY, is known for its comical moments throughout games, with the trio already having multiple instances similar to this already this season. Earlier this month, the booth berated the umpires during a game against the Diamondbacks after a few questionable calls. Advertisement During the ninth inning of the 4-2 loss on May 1, Mets reliever Ty Adcock threw a pitch that clearly hit the bat of Arizona third baseman Eugenio Suarez and landed in catcher Luis Torrens' glove, but umpire John Bacon called the pitch a ball, which left the announcers mortified. Francisco Lindor celebrates with teammates after the final out of the Mets' 8-2 win over the Rockies on May 31, 2025. Corey Sipkin for the NY POST 'John Bacon does not seem to know the difference between a ball hitting a bat and a bat hitting a glove,' Cohen said. 'That was clear a foul tip for strike three. … I mean, what's going on, Keith?' 'Two series in a row just el stinko,' Hernandez replied.
Yahoo
2 days ago
- General
- Yahoo
Francisco Lindor, Juan Soto and David Peterson on Mets' 4-2 win vs. Rockies
Francisco Lindor on 'everybody contributing' in the Mets walk-off win over the White Sox SNY's Steve Gelbs caught up with Francisco Lindor on the field after his sac fly won it for the Mets in the bottom of the ninth. Lindor pointed at all the little things the team did to mount their 13th come-from-behind win this season.
New York Post
3 days ago
- Sport
- New York Post
Ronny Mauricio hits massive homer in quest to return to Mets after injury disaster
Access the Mets beat like never before Join Post Sports+ for exciting subscriber-only features, including real-time texting with Mike Puma about the inside buzz on the Mets. Try it free Ronny Mauricio continues to send reminders that he was a top prospect not all that long ago. The Mets' infielder hit a mammoth home run to right field Thursday with Triple-A Syracuse to continue his blistering showing in the minor leagues in his return from a torn ACL. Advertisement The 24-year-old now has three homers in just 57 minor-league at-bats. Mauricio had long been hyped as a potential starter for the Mets and he showed promise during his 2023 call-up, hitting .292 with an .852 OPS. That momentum, though, came crashing down after he suffered a torn ACL in Dec. 2023 during a Dominican Winter League game and also underwent a procedure to remove scar tissue. Now that he's healthy again, Mauricio is trying to work his way back to Flushing. He's been spending time at second base and third base during his minor-league stint. Advertisement 3 The camera man even lost the ball. @SNY_Mets/X The Mets have Jeff McNeil and Luisangel Acuna at second base, and Brett Baty can play there too, but the road to Queens may not be completely shut. Advertisement McNeil has underwhelmed the last two years, although he's off to a strong start this year. Acuna has cooled off and lost playing time since winning NL Rookie of the Month for April. Any question about Mauricio's readiness, though, is not a pressing once since the team plans to give him time to build back up after one year away. 3 Mauricio moments before homering Thursday. @SNY_Mets/X Mauricio stayed in the minors once his rehab assignment ended, as Mets president of baseball operations David Stearns said earlier this month. Advertisement The infielder has appeared in just 17 minor-league games thus far. Thursday's solo homer came in the eighth inning of Syracuse's 12-3 win over Iowa, the Cubs' Triple-A affiliate. He went 2-for-4 with two runs scored while playing second base. 3 Mauricio during spring training. Corey Sipkin for the NY POST 'He's still got a little way to go to get back to being a healthy player, to get back into that true baseball shape, ready to compete at a high level in the big leagues,' Stearns said earlier this month. 'It's continuing to get him at-bats, get him reps in the minor leagues.'
